Mayne Pharma International Pty Ltd
Insider CIK 1611534 · HPPI 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| INTI Inhibitor Therapeutics, In | J Other | 2021-01-15 | 2021-01-19 | 2,240,488 | — | $0 | 204,083,227 | SEC↗ |
| INTI Inhibitor Therapeutics, In | J Other | 2020-07-15 | 2020-07-20 | 3,189,688 | — | $0 | 201,842,739 | SEC↗ |
| HPPI HedgePath Pharmaceuticals, | J Other | 2019-01-15 | 2019-01-24 | 362,121 | — | $0 | 198,653,051 | SEC↗ |
| HPPI HedgePath Pharmaceuticals, | J Other | 2018-07-15 | 2018-12-19 | 184,798 | — | $0 | 198,290,930 | SEC↗ |
| HPPI HedgePath Pharmaceuticals, | P Buy deriv | 2018-07-05 | 2018-07-06 | 1,739,131 | — | $0 | 1,739,131 | SEC↗ |
| HPPI HedgePath Pharmaceuticals, | P Buy deriv | 2018-07-05 | 2018-07-06 | 1,739,131 | — | $0 | 1,739,131 | SEC↗ |
| HPPI HedgePath Pharmaceuticals, | P Buy deriv | 2018-07-05 | 2018-07-06 | 2,318,841 | — | $0 | 5,797,102 | SEC↗ |
| HPPI HedgePath Pharmaceuticals, | P Buy deriv | 2018-01-10 | 2018-01-11 | 2,608,696 | — | $0 | 2,608,696 | SEC↗ |
| HPPI HedgePath Pharmaceuticals, | P Buy deriv | 2018-01-10 | 2018-01-11 | 2,608,696 | — | $0 | 2,608,696 | SEC↗ |
| HPPI HedgePath Pharmaceuticals, | P Buy deriv | 2018-01-10 | 2018-01-11 | 3,478,261 | — | $0 | 3,478,261 | SEC↗ |
| HPPI HedgePath Pharmaceuticals, | P Buy | 2017-12-19 | 2018-02-12 | 600,000 | $162660.00 | $97.60B | 198,106,132 | SEC↗ |
| HPPI HedgePath Pharmaceuticals, | X Exercise deriv | 2016-11-15 | 2016-11-15 | 4,860,000 | — | $0 | 23,504,236 | SEC↗ |
| HPPI HedgePath Pharmaceuticals, | X Exercise deriv | 2016-11-15 | 2016-11-15 | 333 | — | $0 | 0 | SEC↗ |
| HPPI HedgePath Pharmaceuticals, | X Exercise deriv | 2016-11-15 | 2016-11-15 | 4,750,569 | — | $0 | 0 | SEC↗ |
| HPPI HedgePath Pharmaceuticals, | X Exercise | 2016-11-15 | 2016-11-15 | 4,750,569 | — | $0 | 192,645,799 | SEC↗ |
| HPPI HedgePath Pharmaceuticals, | X Exercise | 2016-11-15 | 2016-11-15 | 4,860,000 | — | $0 | 197,506,132 | SEC↗ |
| HPPI HedgePath Pharmaceuticals, | X Exercise | 2016-11-15 | 2016-11-15 | 333 | — | $0 | 192,646,132 | SEC↗ |
| HPPI HedgePath Pharmaceuticals, | X Exercise deriv | 2016-11-04 | 2016-11-07 | 33,333,000 | — | $0 | 333 | SEC↗ |
| HPPI HedgePath Pharmaceuticals, | X Exercise deriv | 2016-11-04 | 2016-11-07 | 5,500,000 | — | $0 | 4,750,569 | SEC↗ |
| HPPI HedgePath Pharmaceuticals, | X Exercise | 2016-11-04 | 2016-11-07 | 33,333,000 | — | $0 | 187,895,230 | SEC↗ |
| HPPI HedgePath Pharmaceuticals, | X Exercise | 2016-11-04 | 2016-11-07 | 5,500,000 | — | $0 | 154,562,230 | SEC↗ |
| HPPI* HedgePath Pharmaceuticals, | A Award deriv | 2016-05-25 | 2016-05-27 | 28,364,236 | — | $0 | 71,948,138 | SEC↗ |
| HPPI* HedgePath Pharmaceuticals, | A Award | 2016-05-25 | 2016-05-27 | 27,885,000 | — | $0 | 149,062,230 | SEC↗ |
| HPPI HedgePath Pharmaceuticals, | A Award deriv | 2015-05-15 | 2015-05-19 | 33,333,333 | — | $0 | 43,583,902 | SEC↗ |
| HPPI HedgePath Pharmaceuticals, | A Award | 2015-05-15 | 2015-05-19 | 33,333,333 | — | $0 | 121,177,230 | SEC↗ |